Elicio Therapeutics Ownership | Who Owns Elicio Therapeutics?

Elicio Therapeutics Ownership Summary

Elicio Therapeutics is owned by 4.92% institutional investors, 29.76% insiders, and 65.32% retail investors. Knoll capital management is the largest institutional shareholder, holding 4.12% of ELTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.06% of its assets in Elicio Therapeutics shares.

ELTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Elicio Therapeutics	4.92%	29.76%	65.32%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Knoll capital management	630.91K	4.12%	$6.74M
Vanguard group	496.90K	2.98%	$3.96M
Balyasny asset management	244.81K	1.60%	$2.62M
Geode capital management	135.16K	0.88%	$1.45M
Renaissance	121.63K	0.79%	$1.30M
Millennium management	92.76K	0.61%	$991.63K
Marshall wace, llp	74.51K	0.49%	$796.53K
Susquehanna group, llp	70.80K	0.46%	$756.89K
Vanguard fiduciary trust	69.19K	0.45%	$739.63K
Northern trust	59.73K	0.39%	$638.56K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Knoll capital management	630.91K	3.74%	$6.74M
Cm management	25.00K	0.22%	$267.25K
Iridian asset management llc/ct	30.05K	0.13%	$321.25K
683 capital management	56.44K	0.03%	$603.37K
Mayflower financial advisors	10.00K	0.01%	$106.90K
Kingswood wealth advisors	13.80K	0.01%	$147.52K
Moody lynn & lieberson	10.00K	0.01%	$106.90K
Meyer handelman	13.90K	0.00%	$148.58K
Balyasny asset management	244.81K	0.00%	$2.62M
Xtx topco	13.79K	0.00%	$147.36K

Top Buyers

Holder	Shares	% Assets	Change
Balyasny asset management	244.81K	0.00%	106.05K
Renaissance	121.63K	0.00%	93.52K
Millennium management	92.76K	0.00%	92.76K
Vanguard fiduciary trust	69.19K	0.00%	69.19K
Goldman sachs group	57.82K	0.00%	57.82K

Top Sellers

Holder	Shares	% Assets	Change
Marshall wace, llp	74.51K	0.00%	-42.69K
Quantinno capital management lp	-	-	-20.00K
Squarepoint ops	-	-	-16.66K
Occudo quantitative strategies lp	-	-	-15.83K
Jane street group	-	-	-14.99K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	69.19K	0.00%	69.19K	$739.63K
Goldman sachs group	57.82K	0.00%	57.82K	$618.07K
Iridian asset management llc/ct	30.05K	0.13%	30.05K	$321.25K
Hrt financial lp	21.61K	0.00%	21.61K	$231.00K
Hudson bay capital management lp	20.21K	0.00%	20.21K	$216.02K

Sold Out

Holder	Change
Jpmorgan chase	-16.00
Fortitude family office	-93.00
Simplex trading	-103.00
Wells fargo & company/mn	-200.00
Royal bank of canada	-219.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	16	-60.00%	753,220	-63.78%	4	3.17%	10	-56.52%	1	-85.71%
Dec 31, 2025	25	-21.88%	1,060,602	-45.42%	6	4.34%	16	-20.00%	2	-
Sep 30, 2025	31	34.78%	1,936,273	33.46%	12	14.77%	20	100.00%	2	-60.00%
Jun 30, 2025	23	-4.17%	1,450,816	-8.85%	9	5.98%	10	-41.18%	5	150.00%
Mar 31, 2025	24	41.18%	1,591,744	250.55%	12	88.77%	17	325.00%	2	-66.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	384.80K	2.06%	-
A4Investments SICAV SIF ACCI IlanaA2EURH	250.00K	1.34%	-
Vanguard Institutional Extnd Mkt Idx Tr	126.64K	0.68%	5.95K
Lago Erie SICAV	84.72K	0.45%	72.70K
Halley Alinea Global A	61.28K	0.33%	-
Fidelity Extended Market Index	59.37K	0.32%	600.00
Vifag 2002 SICAV	50.00K	0.27%	50.00K
iShares Micro-Cap ETF	28.18K	0.15%	-
Fidelity Total Market Index	21.29K	0.11%	-
Extended Equity Market Fund B	20.31K	0.11%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 12, 2024	Chudnovsky Yekaterina		Buy	$20.00M
Jun 28, 2024	Venkatesan Jay	-	Buy	$250.00K
Jun 28, 2024	Venkatesan Jay	-	Buy	$500.00
Jun 28, 2024	Chudnovsky Yekaterina		Buy	$8.00M
Jun 28, 2024	Chudnovsky Yekaterina		Buy	$16.00K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

ELTX Ownership FAQ

Who Owns Elicio Therapeutics?

Elicio Therapeutics shareholders are primarily institutional investors at 4.92%, followed by 29.76% insiders and 65.32% retail investors. The average institutional ownership in Elicio Therapeutics's industry, Biotech Stocks , is 35.75%, which Elicio Therapeutics falls below.

Who owns the most shares of Elicio Therapeutics?

Elicio Therapeutics’s largest shareholders are Knoll capital management (630.92K shares, 4.12%), Vanguard group (496.9K shares, 2.98%), and Balyasny asset management (244.81K shares, 1.60%). Together, they hold 8.70% of Elicio Therapeutics’s total shares outstanding.

Does Blackrock own Elicio Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Elicio Therapeutics.

Who is Elicio Therapeutics’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Elicio Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.74% of its assets in 630.92K Elicio Therapeutics shares, valued at 6.74M$.

Who is the top mutual fund holder of Elicio Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Elicio Therapeutics shares, with 2.06% of its total shares outstanding invested in 384.8K Elicio Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools